Login
$PSNL
$14.59 -$0.21 (1.42%) After hours

$PSNL SEC Filings

Filed On Filing
16 Nov 2026 425
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 425
06 Nov 2026 425
04 Nov 2026 Form 4: Hall Christopher M, Director

Sold 29,112 shares ($462K)

04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

Reports Q3 clinical test volume of 13,157, clinical revenue of $4.4 million and overall revenue of $25.6 million

03 Nov 2026 425
30 Oct 2026 425
21 Oct 2026 DEFM14A
21 Oct 2026 425
20 Oct 2026 425
20 Oct 2026 SC 13E3/A
06 Oct 2026 425
06 Oct 2026 8-K: Other Events

As previously disclosed, on July 20, 2026, Personalis, Inc., a Delaware corporation (“Personalis” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Tempus AI, Inc., a Nevada corporation (“Tempu...

02 Oct 2026 SC 13E3/A
02 Oct 2026 CT ORDER
22 Sep 2026 Form 4: Moore Stephen Michael, SVP and Chief Legal Officer

Sold 2,068 shares ($33.5K)

22 Sep 2026 Form 4: Chen Richard, President and CMO

Sold 3,998 shares ($64.8K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support